Article
Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.
Clinical chemistry and laboratory medicine - 1 Oct 2011
Markou Athina, Liang Yu, Lianidou Evi
Abstract excerpt
Non-small cell lung carcinomas (NSCLC) account for about 80% of lung cancers and their remarkable heterogeneity manifests in histology, pathogenesis, prognosis, and response to treatments. Recent advances in molecular characterization help stratifying NSCLC patients for their potential benefit from targeting therapies. However, the fundamental mechanisms underlying the tumoral heterogeneity remain poorly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
